Published in Semin Liver Dis on May 01, 1986
Liver transplantation (1). N Engl J Med (1989) 4.53
Acute-on-chronic liver failure: consensus recommendations of the Asian Pacific Association for the study of the liver (APASL). Hepatol Int (2008) 4.16
Acute and acute severe (fulminant) autoimmune hepatitis. Dig Dis Sci (2012) 2.08
Hepatic function after genetically engineered pig liver transplantation in baboons. Transplantation (2010) 1.64
Fulminant hepatic failure in acute hepatitis C: increased risk in chronic carriers of hepatitis B virus. Gut (1999) 1.60
An overview of animal models for investigating the pathogenesis and therapeutic strategies in acute hepatic failure. World J Gastroenterol (2009) 1.54
Orthotopic liver transplantation for acute and subacute hepatic failure in adults. Hepatology (1987) 1.53
Steatosis as a risk factor in liver surgery. Ann Surg (2007) 1.48
Orthotopic liver transplantation in fulminant and subfulminant hepatitis. The Paul Brousse experience. Ann Surg (1995) 1.45
Enhanced replication of a hepatitis B virus mutant associated with an epidemic of fulminant hepatitis. J Virol (1994) 1.44
16, 16 Dimethyl prostaglandin E2 prevents the development of fulminant hepatitis and blocks the induction of monocyte/macrophage procoagulant activity after murine hepatitis virus strain 3 infection. J Clin Invest (1987) 1.33
Molecular mechanisms underlying occult hepatitis B virus infection. Clin Microbiol Rev (2012) 1.30
Clinical application of bioartificial liver support systems. Ann Surg (2004) 1.24
Liver transplantation for fulminant hepatic failure: experience with more than 200 patients over a 17-year period. Ann Surg (2003) 1.15
Biochemical and clinical response of fulminant viral hepatitis to administration of prostaglandin E. A preliminary report. J Clin Invest (1989) 1.15
Auxiliary partial orthotopic liver transplantation for fulminant hepatitis. The Paul Brousse experience. Ann Surg (1996) 1.09
Predictive value of arterial ammonia for complications and outcome in acute liver failure. Gut (2005) 1.07
Acute liver failure in Japan: definition, classification, and prediction of the outcome. J Gastroenterol (2012) 1.02
Human mesenchymal stem cell transfusion is safe and improves liver function in acute-on-chronic liver failure patients. Stem Cells Transl Med (2012) 1.01
Acute liver failure due to hepatic involvement by hematologic malignancy. Dig Dis Sci (1997) 1.00
Internal bioartificial liver with xenogeneic hepatocytes prevents death from acute liver failure: an experimental study. Ann Surg (1998) 0.99
Pig liver xenotransplantation as a bridge to allotransplantation: which patients might benefit? Transplantation (2009) 0.95
Natural course of fulminant hepatic failure: the scenario in Bangladesh and the differences from the west. Saudi J Gastroenterol (2009) 0.91
Auxiliary partial orthotopic versus standard orthotopic whole liver transplantation for acute liver failure: a reappraisal from a single center by a case-control study. Ann Surg (2001) 0.89
Wilson's disease with severe hepatic insufficiency: beneficial effects of early administration of D-penicillamine. Gut (2001) 0.87
Acute liver failure. Wien Klin Wochenschr (2004) 0.84
Lipid overloading during liver regeneration causes delayed hepatocyte DNA replication by increasing ER stress in mice with simple hepatic steatosis. J Gastroenterol (2013) 0.82
Acute liver failure and liver transplantation. Intractable Rare Dis Res (2013) 0.81
Hepatitis B and inflammatory bowel disease: role of antiviral prophylaxis. World J Gastroenterol (2013) 0.81
Portal hypertension in acute liver failure. Gut (1992) 0.81
Evaluation of drug-induced tissue injury by measuring alanine aminotransferase (ALT) activity in silkworm hemolymph. BMC Pharmacol Toxicol (2012) 0.81
G-CSF enhanced SDF-1 gradient between bone marrow and liver associated with mobilization of peripheral blood CD34+ cells in rats with acute liver failure. Dig Dis Sci (2009) 0.80
Liver transplantatation- an overview. Indian J Surg (2012) 0.80
Fulminant hepatic failure secondary to hydroxychloroquine. Gut (1994) 0.80
A rare case of severe acute hepatitis associated with adult-onset still disease dramatically improved by high-dose steroid therapy. Gastroenterol Hepatol (N Y) (2011) 0.80
Evaluation of the prognosis of fulminant viral hepatitis in late pregnancy by the MELD scoring system. Eur J Clin Microbiol Infect Dis (2012) 0.79
Association of tumor necrosis factor-alpha gene promoter polymorphisms with acute viral hepatitis in the Indian population. Dig Dis Sci (2009) 0.79
Comparison of the applicability of two prognostic scoring systems in patients with fulminant hepatic failure. Korean J Intern Med (2007) 0.78
A retrospective autopsy study of histopathologic spectrum and etiologic trend of fulminant hepatic failure from north India. Diagn Pathol (2007) 0.78
Pediatric acute liver failure: variations in referral timing are associated with disease subtypes. Eur J Pediatr (2014) 0.78
Liver transplantation for fulminant hepatitis at Stanford University. J Gastroenterol (2002) 0.77
Hepatic steatosis prevents heme oxygenase-1 induction by isoflurane in the rat liver. World J Gastroenterol (2011) 0.77
Liver transplantation--the first 25 years. West J Med (1988) 0.76
Extracorporeal bioartificial liver for treating acute liver diseases. J Extra Corpor Technol (2011) 0.76
Synergism between hepatocellular injury and shunting in portosystemic encephalopathy (PSE): case report of acute brittle TIPS-induced PSE. Dig Dis Sci (2007) 0.76
Hepatology - Guidelines on Parenteral Nutrition, Chapter 16. Ger Med Sci (2009) 0.76
SPARC (secreted protein acidic and rich in cysteine) knockdown protects mice from acute liver injury by reducing vascular endothelial cell damage. Gene Ther (2014) 0.76
Etiologies and outcomes of acute liver failure in a spanish community. Int J Hepatol (2013) 0.76
Fulminant hepatic failure caused by Salmonella paratyphi A infection. World J Gastroenterol (2006) 0.76
Score model for predicting acute-on-chronic liver failure risk in chronic hepatitis B. World J Gastroenterol (2015) 0.75
Fulminant hepatic failure in association with quetiapine: a case report. J Med Case Rep (2012) 0.75
Liver Illness and Psychiatric Patients. Hepat Mon (2016) 0.75
Auxiliary liver transplantation for acute liver failure. HPB (Oxford) (2004) 0.75
Bioartificial liver support for fulminant hepatic failure. World J Gastroenterol (1999) 0.75
Two difficulty diagnosis cases of severe veno-occlusive disease. Am J Case Rep (2013) 0.75
Acute on Chronic Liver Failure-What is in a 'Definition'? J Clin Exp Hepatol (2016) 0.75
Fulminant hepatic failure. West J Med (1988) 0.75
Liver dysfunction in pregnancy: an important cause of maternal and perinatal morbidity and mortality in Pakistan. Obstet Med (2009) 0.75
Liver transplantation in acute liver failure: A challenging scenario. World J Gastroenterol (2016) 0.75
A Proof of Concept, Phase II Randomized European Trial, on the Efficacy of ALF-5755, a Novel Extracellular Matrix-Targeted Antioxidant in Patients with Acute Liver Diseases. PLoS One (2016) 0.75
Results of liver transplantation in patients with acute liver failure due to Amanita phalloides and paracetamol (acetaminophen) intoxication. Prz Gastroenterol (2015) 0.75
Tolcapone-related fulminant hepatitis: electron microscopy shows mitochondrial alterations. Dig Dis Sci (2000) 0.75
Glipizide treatment with short-term alcohol abuse resulting in subfulminant hepatic failure. Virchows Arch (2003) 0.75
Pattern approach to MR imaging in patients with end-stage hepatic failure: a proposal for a new disease entity "hepatic encephalopathy continuum". Neuroradiology (2008) 0.75
Kidney transplantation in patients with chronic hepatitis B virus infection: is the prognosis worse? Dig Dis Sci (2001) 0.75
Liver transplantation in European patients with the hepatitis B surface antigen. N Engl J Med (1993) 4.43
Long-term histologic improvement and loss of detectable intrahepatic HCV RNA in patients with chronic hepatitis C and sustained response to interferon-alpha therapy. Ann Intern Med (1997) 3.49
Propranolol for prevention of recurrent gastrointestinal bleeding in patients with cirrhosis: a controlled study. N Engl J Med (1981) 3.13
Influence of human immunodeficiency virus infection on chronic hepatitis B in homosexual men. Hepatology (1999) 2.63
Intrahepatic recurrence after resection of hepatocellular carcinoma complicating cirrhosis. Ann Surg (1991) 2.46
Recombinant human alpha-interferon in patients with chronic non-A, non-B hepatitis: a multicenter randomized controlled trial from France. Hepatology (1991) 2.38
Hepatitis B virus DNA in patients with chronic liver disease and negative tests for hepatitis B surface antigen. N Engl J Med (1985) 2.29
Propranolol--a medical treatment for portal hypertension? Lancet (1980) 2.27
Fatal exacerbation of chronic hepatitis B induced by recombinant alpha-interferon. Lancet (1991) 2.14
Portal hypertension, size of esophageal varices, and risk of gastrointestinal bleeding in alcoholic cirrhosis. Gastroenterology (1980) 2.02
Ectopic varices in portal hypertension. Clin Gastroenterol (1985) 1.90
Acute hepatic necrosis and fulminant hepatic failure. Gut (1973) 1.87
Second generation (RIBA) test in diagnosis of chronic hepatitis C. Lancet (1991) 1.84
Relationship between alcohol and tobacco dependencies among alcoholics who smoke. Addiction (1995) 1.81
Etiology of portal vein thrombosis in adults. A prospective evaluation of primary myeloproliferative disorders. Gastroenterology (1988) 1.76
Primary myeloproliferative disorder and hepatic vein thrombosis. A prospective study of erythroid colony formation in vitro in 20 patients with Budd-Chiari syndrome. Ann Intern Med (1985) 1.75
A randomized trial of prednisolone in patients with severe alcoholic hepatitis. N Engl J Med (1992) 1.71
Effect of alcohol consumption on serum hepatitis C virus RNA and histological lesions in chronic hepatitis C. Hepatology (1998) 1.69
Immune complex type glomerulonephritis in cirrhosis of the liver. Am J Pathol (1975) 1.63
Liver adenomatosis. An entity distinct from liver adenoma? Gastroenterology (1985) 1.62
Multivariate analysis of prognostic factors in fulminant hepatitis B. Hepatology (1986) 1.59
Emergency liver transplantation for fulminant hepatitis. Ann Intern Med (1987) 1.56
A randomized controlled study of propranolol for prevention of recurrent gastrointestinal bleeding in patients with cirrhosis: a final report. Hepatology (1984) 1.56
Expression of complement-regulatory proteins in normal and UW-preserved human liver. Gastroenterology (1994) 1.54
Pulmonary hypertension complicating portal hypertension: prevalence and relation to splanchnic hemodynamics. Gastroenterology (1991) 1.52
Sclerosing cholangitis induced by formaldehyde solution injected into the biliary tree of rats. Arch Surg (1990) 1.52
Cigarette smoking and hepatic lesions in patients with chronic hepatitis C. Hepatology (2001) 1.51
Hepatitis after intravenous buprenorphine misuse in heroin addicts. J Hepatol (2001) 1.51
Randomized controlled trial of adenine arabinoside 5'-monophosphate in chronic active hepatitis B: comparison of the efficacy in heterosexual and homosexual patients. Hepatology (1989) 1.50
A controlled study of therapeutic portacaval shunt in alcoholic cirrhosis. Lancet (1976) 1.49
Low prevalence of precore mutations in hepatitis B virus DNA in fulminant hepatitis type B in France. J Hepatol (1993) 1.49
Peliosis hepatis in recipients of renal transplants. Gut (1978) 1.48
Propranolol in prevention of recurrent gastrointestinal bleeding in cirrhotic patients. Lancet (1981) 1.47
Influence of hepatitis G virus infection on the severity of liver disease and response to interferon-alpha in patients with chronic hepatitis C. Ann Intern Med (1997) 1.44
Autoimmune chronic hepatitis exacerbated by alpha-interferon. Ann Intern Med (1992) 1.44
The effect of propranolol on portal hypertension in patients with cirrhosis: a hemodynamic study. Hepatology (1982) 1.44
Transvenous liver biopsy: an experience based on 1000 hepatic tissue samplings with this procedure. Gastroenterology (1982) 1.43
Is the response to recombinant alpha interferon related to the presence of antibodies to hepatitis C virus in patients with chronic non-A, non-B hepatitis? J Hepatol (1990) 1.43
Relative risk of hepatocellular carcinoma in HBsAg positive vs alcoholic cirrhosis. A cross-sectional study. Liver (1990) 1.40
Exacerbation of multiple sclerosis after the administration of recombinant human interferon alfa. JAMA (1989) 1.38
Hepatitis C virus RNA and hepatitis B virus DNA in serum and liver of patients with fulminant hepatitis. Gastroenterology (1993) 1.36
Outcome of Budd-Chiari syndrome: a multivariate analysis of factors related to survival including surgical portosystemic shunting. Hepatology (1999) 1.35
Acute intravascular hemolysis and acute liver failure associated as a first manifestation of Wilson's disease. Ann Intern Med (1977) 1.31
Resection of presumed benign liver tumours. Br J Surg (1993) 1.29
Nodular regenerative hyperplasia of the liver. Report of six cases and review of the literature. Gastroenterology (1978) 1.29
Hepatitis associated with amoxycillin-clavulanic acid combination report of 15 cases. Gut (1992) 1.28
Survival and prognostic factors in patients with severe alcoholic hepatitis treated with prednisolone. Gastroenterology (1996) 1.26
Five-year survival predictive factors in patients with excessive alcohol intake and cirrhosis. Effect of alcoholic hepatitis, smoking and abstinence. Liver Int (2003) 1.25
Auxiliary liver transplantation: regeneration of the native liver and outcome in 30 patients with fulminant hepatic failure--a multicenter European study. Hepatology (1996) 1.23
Drug-induced prolonged cholestasis in adults: a histological semiquantitative study demonstrating progressive ductopenia. Hepatology (1992) 1.22
Passive immunoprophylaxis after liver transplantation in HBsAg-positive patients. Lancet (1991) 1.20
Heterozygous alpha 1-antitrypsin deficiency and cirrhosis in adults, a fortuitous association. Lancet (1975) 1.20
Hepatic vein thrombosis in paroxysmal nocturnal hemoglobinuria. A spectrum from asymptomatic occlusion of hepatic venules to fatal Budd-Chiari syndrome. Gastroenterology (1987) 1.18
Clinical course of spontaneous reactivation of hepatitis B virus infection in patients with chronic hepatitis B. Hepatology (1990) 1.16
Hepatotoxicity of antitubercular treatments. Rationale for monitoring liver status. Drug Saf (1996) 1.16
Idiopathic portal hypertension (perisinusoidal fibrosis) after renal transplantation. Gut (1979) 1.15
[Hepatitis caused by diclofenac]. Gastroenterol Clin Biol (1983) 1.15
Decrease in serum ALT and increase in serum HCV RNA during pregnancy in women with chronic hepatitis C. J Hepatol (2000) 1.15
Ectopic hepatocellular carcinoma arising in the left chest wall: a long-term follow-up. Eur J Gastroenterol Hepatol (2001) 1.15
Fulminant hepatitis with severe lactate acidosis in HIV-infected patients on didanosine therapy. J Intern Med (1994) 1.15
Kinetics of serum cytokines reflect changes in the severity of chronic hepatitis C presenting minimal fibrosis. J Viral Hepat (2002) 1.14
Portosystemic shunt in Budd-Chiari syndrome: long-term survival and factors affecting shunt patency in 25 patients in Western countries. Surgery (1994) 1.13
Successful endoscopic obturation of gastric varices with butyl cyanoacrylate. Hepatology (1989) 1.13
Perhexiline maleate-induced cirrhosis. Gastroenterology (1979) 1.12
Portal hypertension in fulminant viral hepatitis. Gut (1980) 1.12
The intraportal lymphoid nodule and its environment in chronic active hepatitis C: an immunohistochemical study. Hepatology (1993) 1.12
Persistence of systemic and splanchnic hyperkinetic circulation in liver transplant patients. Hepatology (1993) 1.12
Side-to-side portacaval shunt in the treatment of Budd-Chiari syndrome. Gastroenterology (1975) 1.12
Hepatic granulomas and hepatic sarcoidosis. Clin Liver Dis (2000) 1.12
Mechanism for reduced drug clearance in patients with cirrhosis. Gastroenterology (1978) 1.10
Comparison of the effects of a cardioselective and a nonselective beta-blocker on portal hypertension in patients with cirrhosis. Hepatology (1982) 1.09
Inhibition by colchicine of fibrinogen translocation in hepatocytes. J Cell Biol (1975) 1.08